Cancer Immunotherapy: 'Living Drugs' Bring High Hopes, Issues
WASHINGTON – At the annual meeting of the American Association for Cancer Research (AACR) last week, researchers were touting the potential of immunotherapies at the same time as they were trying to figure out how to meet their unique regulatory and developmental challenges.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter